Authors:
DEVEREUX S
CORNEY C
MACDONALD C
WATTS M
SULLIVAN A
GOLDSTONE AH
WARD M
BANK A
LINCH DC
Citation: S. Devereux et al., FEASIBILITY OF MULTIDRUG-RESISTANCE (MDR-1) GENE-TRANSFER IN PATIENTSUNDERGOING HIGH-DOSE THERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR LYMPHOMA, Gene therapy, 5(3), 1998, pp. 403-408
Authors:
HARRISON CN
HUDSON GV
DEVEREUX S
LINCH DC
Citation: Cn. Harrison et al., OUTCOME OF SECONDARY MYELOID MALIGNANCY IN HODGKINS-DISEASE - THE BNLI EXPERIENCE, European journal of haematology, 61(2), 1998, pp. 109-112
Citation: Cn. Harrison et al., QUANTIFICATION OF X-CHROMOSOME INACTIVATION PATTERNS USING RT-PCR OF THE POLYMORPHIC IDURONATE-2-SULFATASE GENE AND CORRELATION OF THE RESULTS OBTAINED WITH DNA-BASED TECHNIQUES, Leukemia, 12(11), 1998, pp. 1834-1839
Authors:
WATTS MJ
SULLIVAN AM
LEVERETT D
PENIKET AJ
PERRY AR
WILLIAMS CD
DEVEREUX S
GOLDSTONE AH
LINCH DC
Citation: Mj. Watts et al., BACKUP BONE-MARROW IS FREQUENTLY INEFFECTIVE IN PATIENTS WITH POOR PERIPHERAL-BLOOD STEM-CELL MOBILIZATION, Journal of clinical oncology, 16(4), 1998, pp. 1554-1560
Citation: Pj. Roberts et al., ACTIVATION OF PHOSPHOLIPASE A(2) DURING DIFFERENTIATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS, Biochemical Society transactions, 26(3), 1998, pp. 233-233
Authors:
PENIKET AJ
PERRY AR
WILLIAMS CD
MACMILLAN A
WATTS MJ
ISAACSON PG
GOLDSTONE AH
LINCH DC
Citation: Aj. Peniket et al., A CASE OF EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE FOLLOWING HIGH-DOSE THERAPY AND CD34-PURIFIED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, Bone marrow transplantation, 22(3), 1998, pp. 307-309
Authors:
WATTS MJ
ADDISON I
INGS SJ
LONG SG
HARTLEY S
WARRINGTON S
BOYCE M
LINCH DC
Citation: Mj. Watts et al., OPTIMAL TIMING FOR COLLECTION OF PBPC AFTER GLYCOSYLATED G-CSF ADMINISTRATION, Bone marrow transplantation, 21(4), 1998, pp. 365-368
Authors:
PERRY AR
WATTS MJ
PENIKET AJ
GOLDSTONE AH
LINCH DC
Citation: Ar. Perry et al., PROGENITOR-CELL YIELDS ARE FREQUENTLY POOR IN PATIENTS WITH HISTOLOGICALLY INDOLENT LYMPHOMAS ESPECIALLY WHEN MOBILIZED WITHIN 6 MONTHS OF PREVIOUS CHEMOTHERAPY, Bone marrow transplantation, 21(12), 1998, pp. 1201-1205
Authors:
ARDESHNA KM
CORNEY CP
INGS SJ
WATTS MJ
LINCH DC
DEVEREUX S
Citation: Km. Ardeshna et al., A CLINICALLY APPLICABLE METHOD FOR THE EX-VIVO GENERATION OF ANTIGEN-PRESENTING CELLS FROM CD34+ PROGENITORS, Bone marrow transplantation, 21, 1998, pp. 55-55
Citation: Rw. Freeburn et al., ACTIVATING POINT MUTATIONS IN THE BETA(C) CHAIN OF THE GM-CSF, IL-3 AND IL-5 RECEPTORS ARE NOT A MAJOR CONTRIBUTORY FACTOR IN THE PATHOGENESIS OF ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 103(1), 1998, pp. 66-71
Authors:
HARRISON CN
GALE RE
WIESTNER AC
SKODA RC
LINCH DC
Citation: Cn. Harrison et al., THE ACTIVATING SPLICE MUTATION IN INTRON-3 OF THE THROMBOPOIETIN GENEIS NOT FOUND IN PATIENTS WITH NONFAMILIAL ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 102(5), 1998, pp. 1341-1343
Authors:
POLLARD Y
WATTS MJ
GRANT D
CHAVDA N
LINCH DC
Citation: Y. Pollard et al., AN ADEQUATE CD34-9500 HEMATOPOIETIC PROGENITOR-CELL (HPC) BLOOD COUNTS( CELL APHERESIS YIELD IS UNLIKELY WITH LOW SYSMEX SE), British Journal of Haematology, 102(1), 1998, pp. 76-77
Citation: K. Pouwels et al., A G-CSF RECEPTOR WITH A 3BP DELETION IN THE CYTOPLASMIC REGION DUE TOALTERNATIVE SPLICING, British Journal of Haematology, 102(1), 1998, pp. 164-164
Authors:
LANGABEER SE
GRIMWADE D
WALKER H
ROGERS JR
BURNETT AK
GOLDSTONE AH
LINCH DC
Citation: Se. Langabeer et al., A STUDY TO DETERMINE WHETHER TRISOMY-8, DELETED 9Q AND TRISOMY-22 AREMARKERS OF CRYPTIC REARRANGEMENTS OF PML RAR-ALPHA, AML1/ETO AND CBFB/MYH11 RESPECTIVELY IN ACUTE MYELOID-LEUKEMIA/, British Journal of Haematology, 101(2), 1998, pp. 338-340
Citation: H. Wheadon et al., DIFFERENTIATION-LINKED CHANGES IN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR MEDIATED SIGNALING IN THE HL-60 PROMYELOCYTIC CELL-LINE, British Journal of Haematology, 101(1), 1998, pp. 82-89
Citation: T. Bernard et al., MUTATIONS OF THE GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA ARE NOT REQUIRED FOR TRANSFORMATION TO ACUTE MYELOID-LEUKEMIA AND MAY BE A BYSTANDER PHENOMENON, British Journal of Haematology, 101(1), 1998, pp. 141-149
Authors:
ROBINSON LG
AUSTIN SJ
OWENJONES CE
LANGABEER SE
LINCH DC
MILLS KI
BURNETT AK
Citation: Lg. Robinson et al., MULTIPLEX PCR FOR THE DETECTION OF PROGNOSTICALLY IMPORTANT GENE REARRANGEMENTS IN ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 101, 1998, pp. 4-4
Authors:
HARRISON CN
MIRESLUIS A
ABERNETHY H
GALE RE
MACHIN SJ
LINCH DC
Citation: Cn. Harrison et al., MARKEDLY REDUCED EXPRESSION OF THE THROMBOPOIETIN RECEPTOR MPL IN PLATELETS FROM PATIENTS WITH MONOCLONAL AND POLYCLONAL ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 101, 1998, pp. 29-29
Authors:
LANGABEER SE
ALLFORD S
GRIMWADE D
CHATTERS SJ
WALKER H
OLIVER FJ
ROGERS JR
ARNOLD J
BAIN BJ
KILBY AM
GOLDSTONE AH
BURNETT AK
PATTERSON KG
LINCH DC
Citation: Se. Langabeer et al., 2 CASES OF T(15-17) NOT ASSOCIATED WITH APL AND THE VALUE OF MOLECULAR SCREENING FOR PML RAR-ALPHA IN AML/, British Journal of Haematology, 101, 1998, pp. 42-42
Citation: Sj. Ings et al., THE POST G-CSF WHITE CELL COUNT IS PREDICTIVE FOR SUBSEQUENT APHERESIS PROGENITOR YIELDS, British Journal of Haematology, 101, 1998, pp. 289-289